This Investor Sold Million: Why Biotech Shares Stay Bullish
A prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
Understanding when it’s too late to start retirement planning is crucial for your financial health. Take action to secure your future now.
19,461 articlesA prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
A federal probe into Tesla's FSD system raises questions for investors about safety, costs, and stock risk. This guid...
A biotech insider sale can spark questions about company momentum. This article digs into the Stoke Therapeutics CMO ...
Tripadvisor (TRIP) entered 2026 with a clear path: optimize advertising, expand bookings, and monetize experiences. I...
April's CPI rose 3.8% year over year, signaling ongoing cost pressure for households. This report captures how famili...
Goldman Sachs argues that a rapid, AI-driven reordering of jobs remains unlikely. There’s little evidence of a broad ...
A stubborn drought threatens the nation’s largest oil export hub in Corpus Christi, forcing lawn bans and possible em...
Greg Abel is stepping into big shoes as Warren Buffett's successor. This article breaks down three bold purchases he ...
When a top Remitly executive sells shares, investors want to know what it means. This guide explains insider sales, h...
A 58-year-old landlord uses a cost segregation study to accelerate depreciation, claiming a $186,000 first-year deduc...
When a company’s CEO purchases thousands of shares, investors sit up and take notice. This article breaks down Brady ...
Georgia's Sickle Cell Disease Protection Act advances with bipartisan support, directing annual Medicaid coverage rev...